To Evaluate the Safety, Tolerability and Pharmacokinetics of K0706 in Plasma and Cerebrospinal Fluid in Healthy Volunteers

Completed · Phase 1

Conditions studied: Healthy

In brief

This is an open-label, multiple-dose study to evaluate the plasma and CSF pharmacokinetics of K0706 in healthy adult male subjects.

Key facts

Study ID
NCT03445338
Run by
Sun Pharma Advanced Research Company Limited
People needed
18
Starts
2018-04-15
Expected to finish
2019-12-06
Last updated by the study team
2020-01-14

Who can join

Age: 18 and older, up to 45. Sex: male. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.